{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:05:22Z","timestamp":1761894322630},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1157\/13086257","type":"journal-article","created":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T18:39:41Z","timestamp":1149187181000},"page":"118-143","source":"Crossref","is-referenced-by-count":6,"title":["Gammagraf\u00eda con MIBG en el neuroblastoma: algo m\u00e1s que una imagen"],"prefix":"10.1016","volume":"25","author":[{"given":"L.","family":"D\u00edez Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mitjavila Casanovas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13086257_bib1","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1200\/JCO.1988.6.12.1874","article-title":"International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma","volume":"6","author":"Brodeur","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1157\/13086257_bib2","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the internacional criteria for neuroblastoma diagnosis, staging and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1157\/13086257_bib3","first-page":"1172","article-title":"Neuroblastoma: a disease requiring a multitude of imaging studies","volume":"45","author":"Kushner","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1157\/13086257_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: biological insights into e clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1157\/13086257_bib5","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/BF00171013","article-title":"A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma","volume":"20","author":"Osmanagaoglu","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.1157\/13086257_bib6","first-page":"679","article-title":"Current concepts on the diagnostic use of MIBG in children","volume":"39","author":"Shulkin","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1157\/13086257_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/1096-911X(200008)35:2<153::AID-MPO18>3.0.CO;2-7","article-title":"False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma","volume":"35","author":"Biasotti","year":"2000","journal-title":"Med Pediatr Oncol"},{"issue":"Suppl 1","key":"10.1157\/13086257_bib8","first-page":"55S","article-title":"MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use","volume":"46","author":"Pashankar","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1157\/13086257_bib9","first-page":"31","article-title":"Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy","volume":"47","author":"Boubaker","year":"2003","journal-title":"Q J Nucl Med"},{"key":"10.1157\/13086257_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0720-048X(00)00289-8","article-title":"Problem in the imaging of three common paediatric solid tumours","volume":"37","author":"McHugh","year":"2001","journal-title":"EJR"},{"key":"10.1157\/13086257_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00043426-199901000-00004","article-title":"Clinical Impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma","volume":"21","author":"Perel","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1157\/13086257_bib12","doi-asserted-by":"crossref","first-page":"BP45","DOI":"10.1007\/s00259-003-1138-9","article-title":"Guideline for radioiodinated MIBG scintigraphy in children","volume":"30","author":"Oliver","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1157\/13086257_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0959-8049(94)00509-4","article-title":"A new 123I-MIBG whole body scan scoring method-application to the prediction of the response of metastases to induction che mo therapy in stage IV neuroblastoma","volume":"31","author":"Ady","year":"1995","journal-title":"E J Cancer"},{"key":"10.1157\/13086257_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<805::AID-CNCR29>3.0.CO;2-3","article-title":"Metastatic neuroblastoma in children older than one year. Prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoroing system","volume":"77","author":"Suc","year":"1996","journal-title":"Cancer"},{"key":"10.1157\/13086257_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-911X(200004)34:4<237::AID-MPO1>3.0.CO;2-J","article-title":"Metaiodobenzylguanidine assessment of metastasic neuroblastoma: observer dependency and chemosensitivity evaluation","volume":"34","author":"Frappaz","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1157\/13086257_bib16","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.2003.09.122","article-title":"Correlation of early metastatic response by 123-I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma","volume":"21","author":"Matthay","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1157\/13086257_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mpo.2950220209","article-title":"What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?","volume":"22","author":"Labreveux de Cervens","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"10.1157\/13086257_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.1998.16.3.953","article-title":"Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry","volume":"16","author":"Ladenstein","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1157\/13086257_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1148\/radiology.182.2.1732972","article-title":"I-131-imaging after bone marrow transplantation for neuroblastoma","volume":"182","author":"Englaro","year":"1992","journal-title":"Radiology"},{"issue":"Suppl 1","key":"10.1157\/13086257_bib20","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/annonc\/4.suppl_1.S45","article-title":"The role of mega-therapy with autologous bone marrow rescue in solid tumour of childhood","volume":"4","author":"Ladenstein","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1157\/13086257_bib21","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1200\/JCO.2003.07.142","article-title":"Impact of MIBG scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemo-therapy","volume":"21","author":"Kushner","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1157\/13086257_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/(SICI)1096-911X(199910)33:4<418::AID-MPO18>3.0.CO;2-9","article-title":"Neuroblastoma maturation by 131I-metaiodobenzylguanidine in chemoresistant neuroblastoma","volume":"33","author":"Arush","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1157\/13086257_bib23","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1097-0142(20010515)91:10<1905::AID-CNCR1213>3.0.CO;2-4","article-title":"Metabolic activity and clinical features of primary ganglio-neuromas","volume":"91","author":"Georger","year":"2001","journal-title":"Cancer"},{"key":"10.1157\/13086257_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00006231-200207000-00011","article-title":"Utility of follow-up studies using meta-123-iodo-benzyl guanidine scintigraphy for detecting recurrent neuroblastoma","volume":"23","author":"Okuyama","year":"2002","journal-title":"Nucl Med Comm"},{"key":"10.1157\/13086257_bib25","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1200\/JCO.2001.19.14.3397","article-title":"Extending PET scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients","volume":"19","author":"Kushner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1157\/13086257_bib26","first-page":"336","article-title":"Nuclear medicine therapy of neuroblastoma","volume":"43","author":"Hoefnagel","year":"1999","journal-title":"Q J Nucl Med"},{"key":"10.1157\/13086257_bib27","first-page":"129","article-title":"Skeletal assessment in neuroblastoma- the pitfalls of iodine-123-MIBG scans","volume":"31","author":"Gordon","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1157\/13086257_bib28","first-page":"1735","article-title":"Iodine-131-metaiodo-benzylguanidine and bone scintigraphy for the detection of neuroblastoma","volume":"33","author":"Shulkin","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1157\/13086257_bib29","first-page":"865","article-title":"Lesion detection in neuroblastoma with iodine-131-MIBG","volume":"34","author":"Hattner","year":"1993","journal-title":"J Nucl Med"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698206752843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698206752843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T03:55:00Z","timestamp":1555646100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212698206752843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0212698206752843"],"URL":"https:\/\/doi.org\/10.1157\/13086257","relation":{},"ISSN":["0212-6982"],"issn-type":[{"value":"0212-6982","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}